Histopathologic Classification of ANCA-Associated Glomerulonephritis

Jennette, 1997, Small-vessel vasculitis, N Engl J Med, 337, 1512, 10.1056/NEJM199711203372106

Mukhtyar, 2008, Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: A systematic review by the European League Against Rheumatism systemic vasculitis task force, Ann Rheum Dis, 67, 1004, 10.1136/ard.2007.071936

Joh, 2008, Renal pathology of ANCA-related vasculitis: Proposal for standardization of pathological diagnosis in Japan, Clin Exp Nephrol, 12, 277, 10.1007/s10157-008-0052-7

Bajema, 2001, Immunopathological aspects of systemic vasculitis, Springer Semin Immunopathol, 23, 253, 10.1007/s002810100074

Aasarod, 2001, Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis, Nephrol Dial Transplant, 16, 953, 10.1093/ndt/16.5.953

Bajema, 1999, Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis, Kidney Int, 56, 1751, 10.1046/j.1523-1755.1999.00758.x

de Lind van Wijngaarden, 2006, Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement, J Am Soc Nephrol, 17, 2264, 10.1681/ASN.2005080870

Hauer, 2002, Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patients, Kidney Int, 62, 1732, 10.1046/j.1523-1755.2002.00605.x

Hauer, 2002, Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies, Nephrol Dial Transplant, 17, 587, 10.1093/ndt/17.4.587

Neumann, 2005, Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis, Nephrol Dial Transplant, 20, 96, 10.1093/ndt/gfh563

Vergunst, 2003, An index for renal outcome in ANCA-associated glomerulonephritis, Am J Kidney Dis, 41, 532, 10.1053/ajkd.2003.50115

Haroun, 2002, Correlation of percentage of normal glomeruli with renal outcome in Wegener's granulomatosis, J Am Soc Nephrol, 22, 497, 10.1159/000065283

Kapitsinou, 2003, Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis, Am J Kidney Dis, 41, 29, 10.1053/ajkd.2003.50013

Berden, 2009, One year renal function predicted by T cell tubulitis and tubular atrophy in patients with ANCA-associated vasculitis treated with rituximab, J Am Soc Nephrol, 20, 306

Bajema, 1996, The renal histopathology in systemic vasculitis: An international survey study of inter- and intra-observer agreement, Nephrol Dial Transplant, 11, 1989, 10.1093/oxfordjournals.ndt.a027086

D'Agati, 2004, Pathologic classification of focal segmental glomerulosclerosis: A working proposal, Am J Kidney Dis, 43, 368, 10.1053/j.ajkd.2003.10.024

Racusen, 1999, The Banff 97 working classification of renal allograft pathology, Kidney Int, 55, 713, 10.1046/j.1523-1755.1999.00299.x

Weening, 2004, The classification of glomerulonephritis in systemic lupus erythematosus revisited, J Am Soc Nephrol, 15, 241, 10.1097/01.ASN.0000108969.21691.5D

Jennette, 1989, Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis, Am J Pathol, 135, 921

Haas, 2000, ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits, Am J Kidney Dis, 36, 709, 10.1053/ajkd.2000.17615

Jennette, 2008, New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies, Curr Opin Rheumatol, 20, 55, 10.1097/BOR.0b013e3282f16c0a

Levy, 2004, Clinical features and outcome of patients with both ANCA and anti-GBM antibodies, Kidney Int, 66, 1535, 10.1111/j.1523-1755.2004.00917.x

Rutgers, 2005, Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase- ANCAs in crescentic glomerulonephritis, Am J Kidney Dis, 46, 253, 10.1053/j.ajkd.2005.05.003

Nasr, 2008, Pauci-immune crescentic glomerulonephritis superimposed on diabetic glomerulosclerosis, Clin J Am Soc Nephrol, 3, 1282, 10.2215/CJN.00740208

Nasr, 2008, Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity, Clin J Am Soc Nephrol, 3, 682, 10.2215/CJN.04391007

Nasr, 2009, Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis, Clin J Am Soc Nephrol, 4, 299, 10.2215/CJN.04060808

Jayne, 1990, Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis, Kidney Int, 37, 965, 10.1038/ki.1990.72

Jennette, 2003, Rapidly progressive crescentic glomerulonephritis, Kidney Int, 63, 1164, 10.1046/j.1523-1755.2003.00843.x

Jayne, 2003, A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies, N Engl J Med, 349, 36, 10.1056/NEJMoa020286

Jayne, 2007, Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis, J Am Soc Nephrol, 18, 2180, 10.1681/ASN.2007010090

Levey, 2000, A simplified equation to predict glomerular filtration rate from serum creatinine, J Am Soc Nephrol, 11, 155A

Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group, Ann Intern Med, 130, 461, 10.7326/0003-4819-130-6-199903160-00002

Senn, 2000, Repeated measures in clinical trials: Simple strategies for analysis using summary measures, Stat Med, 19, 861, 10.1002/(SICI)1097-0258(20000330)19:6<861::AID-SIM407>3.0.CO;2-F